What is the recommended malaria chemoprophylaxis regimen for a traveler to a malaria‑endemic area, considering local Plasmodium species, drug‑resistance patterns, age, pregnancy status, medical history, and drug tolerability?

Malaria Prophylaxis

Primary Recommendation

For travelers to chloroquine-resistant malaria areas (including most of Sub-Saharan Africa), use atovaquone-proguanil, doxycycline 100 mg daily, or mefloquine 250 mg weekly as first-line options, with drug selection based on contraindications, side effect profile, and patient preference. 1, 2

Drug Selection Algorithm by Geographic Resistance Pattern

Chloroquine-Sensitive Areas (Haiti, Central America west of Panama Canal, Middle East)

• Chloroquine 300 mg base weekly is the drug of choice 1
• Start 1-2 weeks before travel, continue weekly during exposure, and for 4 weeks after departure 1

Chloroquine-Resistant Areas (Most of Sub-Saharan Africa, South America, Southeast Asia)

Choose from three first-line options based on patient factors 1, 2:

Atovaquone-proguanil (250 mg/100 mg):

• Dosing: One tablet daily 3
• Timing advantage: Start 1-2 days before travel, continue daily during travel, and only 7 days post-departure (shortest post-exposure duration) 1, 3
• Take with food or milky drink to enhance absorption 3
• Critical pitfall: Absorption reduced with diarrhea or vomiting; closely monitor parasitemia and consider antiemetic 3
• Contraindicated in severe renal impairment (CrCl <30 mL/min) for prophylaxis 3

Doxycycline 100 mg daily:

• Timing: Start 1-2 days before travel, continue daily, and for 4 weeks after departure 4, 5
• Absolute contraindications: Pregnancy (inhibits fetal bone growth, tooth discoloration) and children <8 years 4
• Severe photosensitivity warning: Can be prolonged; mandate high-SPF sunscreen, protective clothing, and sun avoidance 4
• Preferred for mefloquine-resistant areas (Thailand, Myanmar, Cambodia, Laos, Vietnam) 4
• Take with adequate fluids to prevent esophageal ulceration 5

Mefloquine 250 mg weekly:

• Timing: Start 1-2 weeks before travel (allows assessment of tolerability before departure), continue weekly, and for 4 weeks after departure 1
• Neuropsychiatric contraindications: Avoid in patients with seizure history, psychiatric disorders (depression, anxiety, psychosis), or occupations requiring precision movements (pilots, divers) 1
• Critical timing of side effects: 70% of neuropsychiatric reactions occur in first three doses; discontinue immediately if severe mood changes, hallucinations, or seizures develop 1, 2
• Incidence of severe neuropsychiatric effects: 0.01% 2

Special Population Modifications

Pregnant Women

• Chloroquine is the safest option for chloroquine-sensitive areas 1
• For chloroquine-resistant areas: Mefloquine after first trimester 2
• Carry sulfadoxine-pyrimethamine (Fansidar) for presumptive self-treatment if fever develops and medical care unavailable 1
• Doxycycline and primaquine are absolutely contraindicated 4

Children

• <15 kg body weight: Chloroquine only; mefloquine and doxycycline contraindicated 1
• <8 years: Doxycycline contraindicated (permanent tooth discoloration, impaired bone growth) 4
• >8 years for doxycycline: 2 mg/kg once daily up to adult dose 5
• Atovaquone-proguanil pediatric tablets (62.5 mg/25 mg): Dose by weight 3

Severe Renal Impairment (CrCl <30 mL/min)

• Do not use atovaquone-proguanil for prophylaxis 3
• Alternative: Doxycycline or mefloquine (if no contraindications) 1

Prevention of Relapsing Malaria (P. vivax and P. ovale)

For prolonged exposure to endemic areas (missionaries, Peace Corps volunteers):

• Add primaquine 30 mg base daily during the last 2 weeks of the 4-week post-exposure prophylaxis period 1, 4
• Mandatory G6PD testing required before use; contraindicated in G6PD deficiency and pregnancy 1, 4

Essential Mosquito Avoidance Measures (Non-Negotiable Adjunct)

Combine chemoprophylaxis with personal protection 1:

• Remain in well-screened, air-conditioned areas between dusk and dawn 1
• Apply DEET-containing repellents to exposed skin 1, 2
• Wear long sleeves and pants after sunset 1
• Sleep under permethrin-treated bed nets 1, 2
• Apply permethrin spray to clothing 1

Critical Adherence Pitfall

Never stop prophylaxis early: Continue for full 4 weeks post-exposure (except atovaquone-proguanil at 7 days) even if asymptomatic 1. Among US residents diagnosed with malaria, 71.7% had taken no prophylaxis during travel, and more than 80% of US malaria cases are acquired in Africa 6. The mortality rate is 0.3% in the US, with severe malaria occurring in 14% of cases 6.

Treatment Failure Recognition

If fever develops despite prophylaxis or within weeks-months after return, assume prophylaxis failure and treat with a different blood schizonticide 3. P. falciparum has developed chloroquine resistance in most regions worldwide, including Africa 6.